Skip to main content
  • More from ADA
    • Diabetes
    • Clinical Diabetes
    • Diabetes Spectrum
    • ADA Standards of Medical Care
    • ADA Scientific Sessions Abstracts
    • BMJ Open Diabetes Research & Care
  • Subscribe
  • Log in
  • My Cart
  • Follow ada on Twitter
  • RSS
  • Visit ada on Facebook
Diabetes Care

Advanced Search

Main menu

  • Home
  • Current
    • Current Issue
    • Online Ahead of Print
    • Special Article Collections
    • ADA Standards of Medical Care
  • Browse
    • By Topic
    • Issue Archive
    • Saved Searches
    • Special Article Collections
    • ADA Standards of Medical Care
  • Info
    • About the Journal
    • About the Editors
    • ADA Journal Policies
    • Instructions for Authors
    • Guidance for Reviewers
  • Reprints/Reuse
  • Advertising
  • Subscriptions
    • Individual Subscriptions
    • Institutional Subscriptions and Site Licenses
    • Access Institutional Usage Reports
    • Purchase Single Issues
  • Alerts
    • E­mail Alerts
    • RSS Feeds
  • Podcasts
    • Diabetes Core Update
    • Special Podcast Series: Therapeutic Inertia
    • Special Podcast Series: Influenza Podcasts
    • Special Podcast Series: SGLT2 Inhibitors
    • Special Podcast Series: COVID-19
  • Submit
    • Submit a Manuscript
    • Journal Policies
    • Instructions for Authors
    • ADA Peer Review
  • More from ADA
    • Diabetes
    • Clinical Diabetes
    • Diabetes Spectrum
    • ADA Standards of Medical Care
    • ADA Scientific Sessions Abstracts
    • BMJ Open Diabetes Research & Care

User menu

  • Subscribe
  • Log in
  • My Cart

Search

  • Advanced search
Diabetes Care
  • Home
  • Current
    • Current Issue
    • Online Ahead of Print
    • Special Article Collections
    • ADA Standards of Medical Care
  • Browse
    • By Topic
    • Issue Archive
    • Saved Searches
    • Special Article Collections
    • ADA Standards of Medical Care
  • Info
    • About the Journal
    • About the Editors
    • ADA Journal Policies
    • Instructions for Authors
    • Guidance for Reviewers
  • Reprints/Reuse
  • Advertising
  • Subscriptions
    • Individual Subscriptions
    • Institutional Subscriptions and Site Licenses
    • Access Institutional Usage Reports
    • Purchase Single Issues
  • Alerts
    • E­mail Alerts
    • RSS Feeds
  • Podcasts
    • Diabetes Core Update
    • Special Podcast Series: Therapeutic Inertia
    • Special Podcast Series: Influenza Podcasts
    • Special Podcast Series: SGLT2 Inhibitors
    • Special Podcast Series: COVID-19
  • Submit
    • Submit a Manuscript
    • Journal Policies
    • Instructions for Authors
    • ADA Peer Review
LetterLetter: Observations

Type 1 Diabetes and Multiple Sclerosis

Together at last

Janice S. Dorman, Ann R. Steenkiste, James P. Burke, Marco Songini
DOI: 10.2337/diacare.26.11.3192 Published 1 November 2003
Janice S. Dorman
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Find this author on ADS search
  • Find this author on Agricola
  • Search for this author on this site
Ann R. Steenkiste
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Find this author on ADS search
  • Find this author on Agricola
  • Search for this author on this site
James P. Burke
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Find this author on ADS search
  • Find this author on Agricola
  • Search for this author on this site
Marco Songini
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Find this author on ADS search
  • Find this author on Agricola
  • Search for this author on this site

Together at last

Last year, Marrosu et al. (1) reported an increased prevalence of type 1 diabetes among Sardinian individuals with multiple sclerosis and their first-degree relatives. The study was accompanied by a commentary (2) indicating that these autoimmune disorders were “an unlikely alliance” because the HLA haplotype that increases risk for multiple sclerosis (DRB1*15-DQA1*0102-DQB1*0602) protects against type 1 diabetes. To the authors’ knowledge, there have been no published studies of an increased risk of multiple sclerosis for individuals with type 1 diabetes or their families.

Could the association between type 1 diabetes and multiple sclerosis be unique to Sardinia, where the rates of these two disorders are among the highest in the world? Indeed, multiple sclerosis is associated with DRB1*0405-DQA1*0501-DQB1*0301 and DRB1*0301-DQA1*0501-DQB1*0201 in Sardinia (3) and not DRB1*15-DQA1*0102-DQB1*0602, as it is elsewhere in the world. The DRB1*0301-DQA1*0501-DQB1*0201 haplotype is also associated with type 1 diabetes and other autoimmune diseases, such as celiac disease and autoimmune thyroid disease, which are also highly prevalent in Sardinia. Thus, perhaps the association between type 1 diabetes and multiple sclerosis observed in Sardinia is due to its unique HLA haplotype distribution (4).

Alternatively, the “unlikely alliance” hypothesis, which represents the current thinking of many researchers, may have biased us to the point that we failed to look for a possible association between type 1 diabetes and multiple sclerosis. Indeed, we plead guilty to this charge. However, examination of data collected for our Familial Autoimmune and Diabetes (FAD) Study revealed, for the first time, a highly significantly increased prevalence of multiple sclerosis in adults with type 1 diabetes and their first-degree relatives.

The FAD Study focused on the clustering of type 1 diabetes, autoimmune thyroid disease, and rheumatoid arthritis in a cohort of adult type 1 diabetic subjects diagnosed before age 17 years and seen at Childrens’ Hospital of Pittsburgh between 1950 and 1964. Self-report data on the existence of other autoimmune disorders in type 1 diabetic subjects and their siblings and parents were also collected. Seventy-six percent of the eligible probands and 83% of their siblings and parents participated. We recruited 94 nondiabetic control families for comparison.

Two percent of the females with type 1 diabetes and 0.5% of their sisters reported multiple sclerosis. No cases of multiple sclerosis were observed among male probands or male siblings, and multiple sclerosis was totally absent in the control families. Published prevalence rates for multiple sclerosis in the U.S. ranged from 0.06 to 0.17% (∼0.1% on average) for female adults. Thus, we observed a 20-fold increase in the prevalence of multiple sclerosis in our type 1 diabetic women (P = 0.003). Nondiabetic sisters had a fivefold higher risk of multiple sclerosis compared with the general population, which was not statistically significant.

We therefore conclude that adult women with type 1 diabetes are at an enormously increased risk of multiple sclerosis, and that the answer to questions about the clustering of these disorders is that they are “together at last.” Further epidemiologic studies are needed to confirm our findings. Genetic studies are also required to evaluate the DRB1*0301, DRB1*0405, and DRB1*15 extended haplotypes for common alleles at other loci that may contribute to the familial clustering of multiple sclerosis and type 1 diabetes.

Acknowledgments

This research was funded by a grant from National Institute of Diabetes and Digestive and Kidney Diseases (DK-44590)

Footnotes

  • DIABETES CARE

References

  1. Marrosu MG, Cocco E, Lai M, Spinicci G, Pischedda MP, Contu P: Patients with multiple sclerosis and risk of type 1 diabetes in Sardinia, Italy: a cohort study. Lancet 359: 1461–1465, 2002
  2. Lernmark A: Multiple sclerosis and type 1 diabetes: an unlikely alliance. Lancet 359: 1450–1451, 2002
  3. Marrosu MG, Murru MR, Costa, Murru R, Muntoin F, Cucca F: DRB1-DQA1-DQB1 loci and multiple sclerosis predisposition in the Sardinian population. Hum Mol Genet 7: 1235–1237, 2002
  4. Lampis R, Morelli L, DeVirgiliis S, Congia M, Cucca F: The distribution of HLA class II haplotypes reveals that the Sardinian population is genetically differentiated from the other Caucasian populations. Tissue Antigens 56: 515–521, 2000
  5. Dorman JS, Bunker CA: HLA-DQ and type 1 diabetes: a HuGE Review. Epidemiol Rev 22: 218–227, 2000

Navigate

  • Current Issue
  • Standards of Care Guidelines
  • Online Ahead of Print
  • Archives
  • Submit
  • Subscribe
  • Email Alerts
  • RSS Feeds

More Information

  • About the Journal
  • Instructions for Authors
  • Journal Policies
  • Reprints and Permissions
  • Advertising
  • Privacy Policy: ADA Journals
  • Copyright Notice/Public Access Policy
  • Contact Us

Other ADA Resources

  • Diabetes
  • Clinical Diabetes
  • Diabetes Spectrum
  • Scientific Sessions Abstracts
  • Standards of Medical Care in Diabetes
  • BMJ Open - Diabetes Research & Care
  • Professional Books
  • Diabetes Forecast

 

  • DiabetesJournals.org
  • Diabetes Core Update
  • ADA's DiabetesPro
  • ADA Member Directory
  • Diabetes.org

© 2021 by the American Diabetes Association. Diabetes Care Print ISSN: 0149-5992, Online ISSN: 1935-5548.